Preoperative Treatment With Cetuximab and/or IMC-A12
Status:
Completed
Trial end date:
2018-08-15
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to give cetuximab and/or IMC-A12 before surgery
for squamous cell carcinoma of the head and neck, in order to learn if these study drugs may
cause changes in biomarkers. Biomarkers are chemical "markers" in the blood and/or tissue
that may be related to a reaction to study treatment.
The safety of the study treatments will also be studied.